Ph.D. in cellular and molecular biology from the Oswaldo Cruz Foundation. His expertise includes molecular biology, bioinformatics, and gene editing, focusing on infectious and neurodegenerative diseases. He is currently investigating the potential of epigenetic editing using CRISPR-Cas9 technology to treat neurodegenerative diseases.
